Vascular Web Logo

SVS  SVS Foundation

 PS192. Inhibition of Hypoxia Inducible Factor (HIF)-1α Suppresses Formation and Progression of Experimental Abdominal Aortic Aneurysms (AAAs)

Wei Wang1, Baohui Xu1, Haojun Xuan1, Hiroki Tanaka1, Martin Rouer1, Keith J. Glover1, Naoki Fujimura1, Xiaolei Hu1, Mary Gerritsen1, Sara A. Michie2, Ronald L. Dalman1
1Vascular Surgery, Stanford University School of Medicine, Stanford, CA; 2Pathology, Stanford University School of Medicine, Stanford, CA.

OBJECTIVES: HIF-1α critically regulates angiogenesis, a histopathological feature of AAA disease. This study evaluated whether 2-methyoxyestradiol (2-ME) or digoxin, known HIF-1α inhibitors, modulate experimental AAAs.
METHODS: AAAs were created in male C57BL/6J mice via transient intra-aortic porcine pancreatic elastase (PPE) infusion. Mice were treated with vehicle, 2-ME (50mg/kg/day) or digoxin (2mg/kg/day) starting prior to, or following, PPE infusion. Therapeutic efficacy was evaluated using serial aortic diameter ultrasound imaging and histological analyses at sacrifice.
RESULTS: mRNAs for HIF-1α and four genes regulated by HIF-1α were up-regulated in aneurysmal aortae. In vehicle-treated mice, aortic diameters enlarged remarkably and persistently beginning the third day following PPE infusion. Pretreatment with either 2-ME, or digoxin, significantly attenuated subsequent PPE-induced aortic expansion (Figure 1). Initiated 4 days following PPE infusion, treatment with both drugs also prevented further enlargement of existing AAAs. Histologically, treatment with 2-ME or digoxin was associated with preserved medial smooth muscle cellularity and elastic fibers and reduced mural leukocyte infiltration and angiogenesis.
CONCLUSIONS: Pharmacological inhibition of HIF-1α suppresses formation and progression of PPE-induced AAAs, suggesting the translational potential for HIF-1α inhibition in human AAA therapy.
AUTHOR DISCLOSURES: R. L. Dalman: Nothing to disclose; N. Fujimura: Nothing to disclose; M. Gerritsen: Nothing to disclose; K. J. Glover: Nothing to disclose; X. Hu: Nothing to disclose; S. A. Michie: Nothing to disclose; M. Rouer: Nothing to disclose; H. Tanaka: Nothing to disclose; W. Wang: Nothing to disclose; B. Xu: Nothing to disclose; H. Xuan: Nothing to disclose.

Posted April 2013

Contact Us

Society for Vascular Surgery
633 North Saint Clair Street, 22nd Floor | Chicago, IL 60611
Phone: 312-334-2300 | 800-258-7188
Fax: 312-334-2320

Follow Us


VascularWeb® is the prime source for all vascular health and disease information, and is presented by the Society for Vascular Surgery®. Its members are vascular surgeons, specialists, and vascular health professionals who are specialty-trained in all treatments for vascular disease including medical management, non-invasive procedures, and surgery.